FMS3-insulin

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameFMS3-insulin

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionOrnithine decarboxylase stimulantsPhosphokinases stimulantsTyrosine aminotransferase stimulants

TargetsOrnithine decarboxylasePhosphokinasesTyrosine aminotransferase

Therapy Area/IndicationsDiabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesN/A

China Registration ClassN/A

Active CompaniesN/A

Inactive Companies +[1] N/A

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 1

ATC CodeN/A